Nicoletta Cordani

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Topics

Acute Myeloid Leukemia

Breast Cancer Cells

Ejection Fraction

Top Venues

International journal of molecular sciences

NPJ precision oncology

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Elisa Duranti, Nicoletta Cordani, Chiara Villa
Edaravone: A Novel Possible Drug for Cancer Treatment? International journal of molecular sciences 25 (3) (2024)
Matteo Villa, Federica Malighetti, Elisa Sala, Geeta G Sharma, Giulia Arosio, Maria Gemelli, Chiara Manfroni, Diletta Fontana, Nicoletta Cordani, Raffaella Meneveri, Alfonso Zambon, Rocco Piazza, Fabio Pagni, Diego Luigi Cortinovis, Luca Mologni
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients. NPJ precision oncology 8 (1) (2024)
Alice Ilari, Viola Cogliati, Noorhan Sherif, Emanuela Grassilli, Daniele Ramazzotti, Nicoletta Cordani, Giorgio Cazzaniga, Camillo Di Bella, Maria Luisa Lavitrano, Marina Elena Cazzaniga, Maria Grazia Cerrito
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer. Biomedicines 12 (2) (2024)
Elisa Duranti, Nicoletta Cordani, Chiara Villa
Edaravone: A Novel Possible Drug for Cancer Treatment? International journal of molecular sciences 25 (3) (2024)
Elisa Duranti, Nicoletta Cordani, Chiara Villa
Edaravone: A Novel Possible Drug for Cancer Treatment? International journal of molecular sciences 25 (3) (2024)
Alice Ilari, Viola Cogliati, Noorhan Sherif, Emanuela Grassilli, Daniele Ramazzotti, Nicoletta Cordani, Giorgio Cazzaniga, Camillo Di Bella, Maria Luisa Lavitrano, Marina Elena Cazzaniga, Maria Grazia Cerrito
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer. Biomedicines 12 (2) (2024)
Elisa Duranti, Nicoletta Cordani, Chiara Villa
Edaravone: A Novel Possible Drug for Cancer Treatment? International journal of molecular sciences 25 (3) (2024)
Matteo Villa, Federica Malighetti, Elisa Sala, Geeta G Sharma, Giulia Arosio, Maria Gemelli, Chiara Manfroni, Diletta Fontana, Nicoletta Cordani, Raffaella Meneveri, Alfonso Zambon, Rocco Piazza, Fabio Pagni, Diego Luigi Cortinovis, Luca Mologni
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients. NPJ precision oncology 8 (1) (2024)
Matteo Villa, Federica Malighetti, Elisa Sala, Geeta G Sharma, Giulia Arosio, Maria Gemelli, Chiara Manfroni, Diletta Fontana, Nicoletta Cordani, Raffaella Meneveri, Alfonso Zambon, Rocco Piazza, Fabio Pagni, Diego Luigi Cortinovis, Luca Mologni
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients. NPJ precision oncology 8 (1) (2024)
Nicoletta Cordani, Daniela Lisini, Valentina Cocce, Giuseppe Paglia, Ramona Meanti, Maria Grazia Cerrito, Pietro Tettamanti, Luca Bonaffini, Francesca Paino, Giulio Alessandri, Angela Marcianti, Aldo Bruno Gianni, Chiara Villa, Mario Mauri, Luca Mologni, Antonio Torsello, Augusto Pessina, Marina Elena Cazzaniga
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC). International journal of molecular sciences 24 (6) (2023)
Nicoletta Cordani, Daniela Lisini, Valentina Cocce, Giuseppe Paglia, Ramona Meanti, Maria Grazia Cerrito, Pietro Tettamanti, Luca Bonaffini, Francesca Paino, Giulio Alessandri, Angela Marcianti, Aldo Bruno Gianni, Chiara Villa, Mario Mauri, Luca Mologni, Antonio Torsello, Augusto Pessina, Marina Elena Cazzaniga
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC). International journal of molecular sciences 24 (6) (2023)
Nicoletta Cordani, Tommaso Bianchi, Luca Carlofrancesco Ammoni, Diego Luigi Cortinovis, Marina Elena Cazzaniga, Andrea Alberto Lissoni, Fabio Landoni, Stefania Canova
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective. International journal of molecular sciences 24 (15) (2023)
Nicoletta Cordani, Luca Mologni, Rocco Giovanni Piazza, Pietro Tettamanti, Viola Cogliati, Mario Mauri, Matteo Villa, Federica Malighetti, Camillo Di Bella, Marta Jaconi, Maria Grazia Cerrito, Guido Cavaletti, Maria Luisa Lavitrano, Marina Elena Cazzaniga
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells. International journal of molecular sciences 24 (22) (2023)
Nicoletta Cordani, Daniela Lisini, Valentina Cocce, Giuseppe Paglia, Ramona Meanti, Maria Grazia Cerrito, Pietro Tettamanti, Luca Bonaffini, Francesca Paino, Giulio Alessandri, Angela Marcianti, Aldo Bruno Gianni, Chiara Villa, Mario Mauri, Luca Mologni, Antonio Torsello, Augusto Pessina, Marina Elena Cazzaniga
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC). International journal of molecular sciences 24 (6) (2023)
Marina Elena Cazzaniga, Serena Capici, Nicoletta Cordani, Viola Cogliati, Francesca Fulvia Pepe, Francesca Riva, Maria Grazia Cerrito
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows. Journal of clinical medicine 11 (16) (2022)
Viola Cogliati, Serena Capici, Francesca Fulvia Pepe, Pierluigi di Mauro, Francesca Riva, Federica Cicchiello, Claudia Maggioni, Nicoletta Cordani, Maria Grazia Cerrito, Marina Elena Cazzaniga
How to Treat HR+/HER2- Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story. Life (Basel, Switzerland) 12 (3) (2022)
Marina Elena Cazzaniga, Nicoletta Cordani, Serena Capici, Viola Cogliati, Francesca Riva, Maria Grazia Cerrito
Metronomic Chemotherapy. Cancers 13 (9) (2021)
Sara Redaelli, Monica Ceccon, Marina Zappa, Geeta Geeta Sharma, Cristina Mastini, Mario Mauri, Marion Nigoghossian, Luca Massimino, Nicoletta Cordani, Francesca Farina, Rocco Piazza, Carlo Gambacorti-Passerini, Luca Mologni
Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer. Cancer research 78 (24) (2018)